title: [Oral anti-diabetes medicines, an update].
abstract: The use of oral anti-diabetes medicines should be considered when nutritional control methods and physical exercise programs have failed. These medicines have several types of active mechanisms: to stimulate pancreatic secretion of insulin, to delay the absorption of carbohydrates in the intestines, to sensitize tissues to the action of insulin. Sulfonylureas are the pharmaceutical group most commonly utilized in the treatment of type 2 diabetes mellitus.
authors.affiliation: Enfermera Unidad de Endocrinología, Hospital Universitario Marqués de Valdecilla, Santander. sandy21@satse.es
authors.forename: Sandra
authors.initials: S
authors.lastname: Melero Paredes
authors.forename: Noelia
authors.initials: N
authors.lastname: Antolínez de Abia
mesh_terms: D000284:Administration, Oral; D001645:Biguanides / Q000009:adverse effects / Q000627:therapeutic use*; D015992:Body Mass Index; D000075202:Contraindications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D009042:Motivation; D009765:Obesity / Q000453:epidemiology; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D014312:Trisaccharides / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D001645:Biguanides; D007004:Hypoglycemic Agents; D010880:Piperidines; D013453:Sulfonylurea Compounds; D014312:Trisaccharides